Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial

American Journal of Psychiatry

Volumn 160, Issue 2, 2003, Pages 255-261

  McElroy, Susan L ^a   Arnold, Lesley M ^b   Shapira, Nathan A ^b   Keck Jr , Paul E ^b   Rosenthal, Norman R ^b   Karim, M Rezaul ^b   Kamin, Marc ^b   Hudson, James I ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOPIRAMATE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

ARTICLE; BACKACHE; BINGE EATING DISORDER; BODY MASS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; LANGUAGE DISABILITY; MALE; NAUSEA; NERVOUSNESS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; XEROSTOMIA; AMBULATORY CARE; BULIMIA; COMORBIDITY; DRUG ADMINISTRATION;

AMBULATORY CARE; ANTICONVULSANTS; BULIMIA; COMORBIDITY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FRUCTOSE; HUMANS; OBESITY; PLACEBOS; TREATMENT OUTCOME;

EID: 0037315937     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.2.255     Document Type: Article

References (26)

1. Williamson DA, Martin CK: Binge eating disorder: a review of the literature after publication of DSM-IV. Eat Weight Disord 1999; 4:103-114
2. Agras S: Treatment of binge-eating disorder, in Treatment of Psychiatric Disorders, 3rd ed. Edited by Gabbard GO. Washington, DC, American Psychiatric Press, 2001, pp 2209-2219
3. Fairburn CG, Brownell KD (eds): Eating Disorders and Obesity, 2nd ed. New York, Guilford, 2002
4. Smith DE, Marcus MD, Lewis CE, Fitzgibbon M, Schreiner P: Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998; 20:227-232
5. Devlin MJ, Yanovski SZ, Wilson GT: Obesity: what mental health professionals need to know. Am J Psychiatry 2000; 157:854-866
6. Wadden TA, Sarwer DB, Womble LG, Foster GD, McGuckin BG, Schimmel A: Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001; 81:1001-1024
7. Stunkard A, Berkowitz R, Tanrikut C, Reiss E, Young L: d-Fenfluramine treatment of binge eating disorder. Am J Psychiatry 1996; 153:1455-1459
8. Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE Jr, Carter WP, Mitchell JE, Strakowski SM, Pope HG Jr, Coleman BS, Jonas JM: Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998; 155:1756-1762
9. McElroy SL, Casuto LS, Nelson EB, Lake KA, Soutullo CA, Keck PE Jr, Hudson JI: Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000; 157:1004-1006
10. Arnold LA, McElroy SL, Hudson JI, Welge JA, Bennet AJ, Keck PE Jr: A placebo-controlled trial of fluoxetine in the treatment of binge eating disorder. J Clin Psychiatry 2002; 63:1028-1033
11. McCann UD, Agras WS: Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990; 147:1509-1513
12. Laederach-Hofmann K, Graf C, Horber F, Lippuner K, Lederer S, Michel R, Schneiderr M: Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord 1999; 26:231-244
13. Wilfley DE, Welch R, Stein Rl, Spurrell EB, Cohen LR, Saelens BE, Dounchis JZ, Frank MA, Wiseman CV, Matt GE: A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 2002; 59:713-721
14. Langtry HD, Gillis JC, Davis R: Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997; 54:752-773
15. Shapira NA, Goldsmith TD, McElroy SL: Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 2000; 61:368-372
16. Smith U, Axelsen M, Hellebö-Johanson E, Lundgren B, Ben-Menachem E: Topiramate, a novel antiepileptic drug, reduces body weight and food intake in obesity (abstract). Obesity Res 2000; 8(Suppl 1):105
17. Stanley BG, Ha LH, Spears LC, Dee MG II: Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 1993; 613:88-95
18. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry 1989; 46:1012-1016
19. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1996
20. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
21. Diggle PJ, Liang K, Zeger SL: Analysis of Longitudinal Data. Oxford, UK, Oxford University Press, 1995
22. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT: Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50:739-750
23. Berlant J, van Kammen DP: Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 2002; 63:15-20
24. Schiffer WK, Gerasimov MR, Marsteller DA, Geiger J, Barnett C, Alexoff DL, Dewey SL: Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 2001; 42:196-198
25. Zheng H, Patterson C, Berthoud H-R: Behavioral analysis of anorexia produced by hindbrain injections of AMPA receptor antagonist NBQX in rats. Am J Physiol Regulatory Integrative Comp Physiol 2002; 282:R147-R155
26. Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y: Influence of topiramate in the regulation of energy balance. Nutrition 2000; 16:961-966